Robert de Luccia

Robert de Luccia

Fortuna: 100 390 $ al 31/05/2026

80 años
Health Technology
Consumer Durables
Consumer Services

Perfil

Mr. Robert J.
de Luccia
is an Executive Chairman at Acurx Pharmaceuticals, Inc. and a Lead Independent Director at IBEX Technologies, Inc. He is on the Board of Directors at PLx Pharma, Inc. and IBEX Technologies, Inc. Mr. de Luccia was previously employed as an Executive Chairman by Dipexium Pharmaceuticals, Inc., a Chairman, President & Chief Executive Officer by MacroChem Corp., a President & Chief Executive Officer by Immunomedics, Inc., a Chief Executive Officer by Morris Plains Property LLC, a Vice President-Marketing & Sales Operations by Pfizer Inc., a President by Sanofi Winthrop, a President by Sanofi-Aventis U.S.
LLC, and a President by Sterling Winthrop, Inc. He also served on the board at Topigen Pharmaceuticals, Inc. He received his undergraduate degree from Iona College and an MBA from Iona College.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
20/04/2026 50.702 ( 3,2 % ) 100 390 $ 31/05/2026

Cargos activos de Robert de Luccia

EmpresasCargoInicio
IBEX TECHNOLOGIES Director/Miembro de la Junta 01/01/2000
ACURX PHARMACEUTICALS, INC. Fundador 01/07/2017
PLX PHARMA WINDDOWN CORP. Director/Miembro de la Junta 01/04/2017

Antiguos cargos conocidos de Robert de Luccia.

EmpresasCargoFin
Fundador 01/04/2017
Director Ejecutivo 01/01/2009
IMMUNOMEDICS, INC. Director Ejecutivo 01/01/1999
Presidente -
Director Ejecutivo -
Ver el detalle de la experiencia de Robert de Luccia.

Formación de Robert de Luccia.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

40

Relaciones de 1er grado

13

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Durables

Consumer Services

Health Technology

Health Technology

Finance

Health Technology

Health Technology

  1. Bolsa de valores
  2. Insiders
  3. Robert de Luccia
-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN